Ladenburg Thalmann Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
CFA
CAN
BCI
CAN
Ladenburg Thalmann Financial Services's ARKG Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services reduced its ARK Genomic Revolution ETF (ARKG) stake by 20% in Q4 2019, selling an estimated $311K and leaving 38,992 shares worth $1.13M. The position accounts for 0.01% of the portfolio, ranked #1207.
Ladenburg Thalmann Financial Services first reported a position in ARKG in Q1 2016 and has held it in 16 quarters since. The position peaked at $1.17M in Q3 2019. 93 funds tracked by Wall St. Rank hold ARKG as of Q4 2019.
- Ladenburg Thalmann Financial Services held 38,992 shares of ARK Genomic Revolution ETF worth $1.13M as of Q4 2019.
- Ladenburg Thalmann Financial Services sold 9,801 ARK Genomic Revolution ETF shares in Q4 2019, an estimated $311K.
- ARK Genomic Revolution ETF made up 0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1207 holding.
- Ladenburg Thalmann Financial Services first reported a position in ARK Genomic Revolution ETF in Q1 2016 and has held it in 16 quarters since.
- Ladenburg Thalmann Financial Services's ARK Genomic Revolution ETF position peaked at $1.17M in Q3 2019.
- 93 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.